Cargando…
BATCAVE: calling somatic mutations with a tumor- and site-specific prior
Detecting somatic mutations withins tumors is key to understanding treatment resistance, patient prognosis and tumor evolution. Mutations at low allelic frequency, those present in only a small portion of tumor cells, are particularly difficult to detect. Many algorithms have been developed to detec...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003682/ https://www.ncbi.nlm.nih.gov/pubmed/32051931 http://dx.doi.org/10.1093/nargab/lqaa004 |